S U M M A R Y Plasma adrenaline and noradrenaline concentrations were measured in 21 patients after subarachnoid haemorrhage and in 13 control patients. Plasma noradrenaline concentrations were significantly raised in patients recovering from subarachnoid haemorrhage, confirming clinical evidence of overactivity of the sympathetic nervous system. Plasma noradrenaline concentrations in patients with a poor result were significantly higher at the time of admission than in patients with a good result, and the differences became more significant two to three days later. Therefore, the measurement of plasma noradrenaline concentrations may be a valuable test to assist clinical assessment in distinguishing between the two groups preoperatively.
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There is indirect evidence of autonomic nervous system dysfunction after subarachnoid haemorrhage. In the hours after a subarachnoid haemorrhage systemic hypertension is common, and electrocardiographic changes suggestive of myocardial ischaemia or even frank infarction, which have been interpreted as evidence of overactivity of the sympathetic nervous system, have been reported (Weintraub and McHenry, 1974) . Greenhoot and Reichenbach (1969) reported six fatal cases of subarachnoid haemorrhage in which recent subendocardial haemorrhages and myofibrillar degeneration were evident at postmortem examination, while Smith and Tomlinson (1954) found subendocardial haemorrhage in 29 of a series of 235 patients at necropsy; such changes have been produced in experimental animals by the intravenous infusion of noradrenaline (Szakacs and Mehlman, 1960) . Plasma catecholamines were measured in man after subarachnoid haemorrhage by Peerless and Griffiths in 1972 using a fluorimetric assay. They found raised plasma catecholamine levels, particularly in patients who were comatose or moribund. How-ever, they did not measure plasma catecholamine concentrations in a control group of acutely ill patients, and were, therefore, unable to show whether the measured increases in plasma catecholamines were specific to subarachnoid haemorrhage. This paper reports plasma adrenaline and noradrenaline concentrations measured using a more sensitive radioenzymatic method in 21 patients with subarachnoid haemorrhage from a ruptured intracranial aneurysm, and compares them with the concentration found in 13 control patients admitted to hospital for other reasons.
Patients SUBARACHNOID HAEMORRHAGE GROUP
Twenty-one non-consecutive patients who did not receive any drugs known to alter plasma catecholamine concentrations were studied. The patients had been referred to the neurosurgical department with a subarachnoid haemorrhage confirmed by obtaining bloodstained cerebrospinal fluid on lumbar puncture. The presence of one or more intracranial aneurysms was demonstrated by angiography, and all the patients were considered suitable for eventual neurosurgery. They were awake, or drowsy with no major neurological deficit (Botterell grade 1, 2, or 3) (Boterell et al.,therefore the group studied was composed of patients making a good recovery from the initial episode of subarachnoid haemorrhage.
The purpose of the study was explained to these patients and their consent obtained. Within 24 hours of admission a venous blood sample was collected for plasma catecholamines, and in 14 of them a further sample was collected two to 12 hours before they underwent surgery or, when they were deferred as unfit for surgery. The time of collection of these samples after subarachnoid haemorrhage is shown in Table 1 . Six weeks after neurosurgery the clinical state of the patients was assessed using the method of Loach and de Azevedo (1976) . The "good result" group consisted of patients whose clinical state was good (back at work), or fair (independent, but unable to return to their original work because of a residual neurological deficit), while those who were poor (still needed help in daily life) or had died were called the "poor result" group. The patients for whom surgery was deferred because of a deteriorating neurological state were included in the "poor result" group.
CONTROL GROUP
The control group consisted of two types of patients. (a) Six patients who were admitted for cardiac catheterisation for investigation of a cardiac murmur but who were not in cardiac failure or taking any drugs. A venous blood sample for estimation of plasma catecholamines was obtained from these patients within two hours of admission and another just before their discharge after 60-72 hours stay in hospital. (b) Seven patients who were admitted with one of the following acute clinical problems: lobar pneumonia, acute appendicitis (three patients), urinary tract infection and cystitis, systemic lupus erythematosus accompanied by fever, and pleurisy. Blood samples were collected from these patients within two hours of admission and three or four days later when their acute symptoms were gradually subsiding.
Methods
All blood samples were taken from an antecubital vein, after at least 30 min of quiet supine bed rest, into a lithium heparin tube containing solid reduced glutathione as the antioxidant, and placed in ice. They were immediately centrifuged at 2000 g at 40 for five minutes, and the plasma separated and stored at -20°. The samples were assayed within five to six days of collection in duplicate by the method of Hortnagl et al. (1977) . The data were analysed using Student's two-tailed unpaired t test.
Results
There was no significant difference between the ages (27-64 years; 24-64 years) and sexes (M 9: F 11; M 6: F 7) of the patients in the subarachnoid haemorrhage group and the control group. Plasma adrenaline concentrations in the patients with subarachnoid haemorrhage were raised and significantly greater than the concentrations in patients admitted for cardiac catheterisation (P<0.02) ( and a "poor result" group further differences were apparent, particularly in plasma noradrenaline concentrations (Table 2 ). In patients with a good result, plasma noradrenaline concentrations were raised on admission but were not significantly different from those of patients with other pathology. In the poor result group plasma noradrenaline concentrations were markedly increased and significantly higher than the concentrations in patients with other pathology (P<O.001), and in the patients with subarachnoid haemorrhage and a good result (P<0.01) (Fig. 1) .
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Discussion
The significance of these results is twofold. Firstly, at the time of admission after a subarachnoid haemorrhage there are increased circulating concentrations of plasma adrenaline and noradrenaline (Table 1) . Since the increase in plasma adrenaline is similar to that in subgroup (b) of the control group of patients, this rise is probably not specifically due to subarachnoid haemorrhage. However, the increased plasma noradrenaline concentrations are significantly different from the concentrations in both control subgroups of patients, indicating that there is increased sympathetic nervous system activity in the patients with subarachnoid haemorrhage. Although it is difficult to know just how much noradrenaline released from the sympathetic postganglionic nerve endings escapes neuronal and extraneuronal uptake and metabolism to enter the plasma, other workers have used plasma noradrenaline concentrations as an index of sympathetic nervous system activity (Von Euler, 1964; Mathias et al., 1976) . These increased concentrations are in accord with clinical observations which have been interpreted as evidence of increased sympathetic nervous system activity such as systemic hypertension and ischaemic electrocardiographic changes (Greenhoot and Reichenbach, 1969; Weintraub and McHenry, 1974) .
The mechanism of sympathetic nervous system activation after subarachnoid haemorrhage is obscure. It is possible that this activation originates in the hypothalamus, and Hammermeister and Reichenbach (1969) reported a patient with transmural myocardial infarction after subarachnoid haemorrhage who also had pyknosis and chromatolysis of cells of the hypothalamus: in experimental animals hypothalamic stimulation may produce electrocardiographic changes silnilar to those described in humans after subarachnoid haemorrhage (Melville et al., 1963) . The blood supply of the hypothalamus is through fine perforating vessels arising from the internal carotid arteries and the posterior communicating arteries and the proximal part of the anterior cerebral arteriesall common sites for intracranial aneurysms. Rupture of an aneurysm which disrupts these fine vessels or leads to vasospasm of the main trunk could diminish hypothalamic blood supply leading to damage, alteration in hypothalamic function and increase in peripheral sympathetic nervous system activity.
Since there appears to be good evidence of sympathetic nervous system activity in these patients, early consideration might be given to the use of /3-adrenergic blocking agents to prevent myocardial damage, particularly if the patient has electrocardiographic abnormalities or is hypertensive.
Secondly, at the time of admission the patients with a poor result may be clinically indistinguishable from those with a good result. In the poor result group the plasma noradrenaline concentrations measured at the time of admission or two to three days later differed significantly from the concentrations found in the good result group and in both the control groups of patients (Table 1) . Therefore, the measurement of plasma noradrenaline concentrations after admission to hospital may assist clinical assessment in selecting suitable patients for neurosurgrey. 
